Vaxcyte PCVX
NASDAQ PCVX
$62.85 -0.38 (-0.60%)
At close: Oct 22, 2026 · 4:00 PM EDT

Vaxcyte (PCVX) Net Preferred Shares Issued and Repurchased (2020)

Updated

Analysis

Vaxcyte (PCVX) Net Preferred Shares Issued and Repurchased (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Vaxcyte 9.10 Bn 2.60 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 4,000.00
Mar 31, 2020 109.88 Mn
API Access

Vaxcyte Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=PCVX&period=max&api_key=YOUR_API_KEY